Kexing Biopharm Co., Ltd.SSE: 688136

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

Later from Kexing Biopharm

All Kexing Biopharm news releases